Skip to content
Assyro AI
Back to Glossary
General

Quality System(QS)

Quality System is the documented management framework a regulated manufacturer uses to direct product quality across the lifecycle, distinct from GMP's minimum production rules by adding management responsibility, monitoring, and continual improvement obligations.

Usage Examples

  • The auditor asked to see how our quality system feeds deviation trends into management review.
  • That site has a quality system on paper and no evidence anyone acts on it.
  • Our quality system has to cover development, not just commercial manufacturing.

What is Quality System (QS)?

Quality System is the documented management framework a regulated manufacturer uses to direct product quality across the lifecycle, distinct from GMP's minimum production rules by adding management responsibility, monitoring, and continual improvement obligations.

A quality system exists because testing finished product cannot prove the process that made it was in control. Regulators needed manufacturers to own quality as a standing management function rather than a final inspection step, so ICH Q10 defines the pharmaceutical quality system as a management system to direct and control a pharmaceutical company with regard to quality.

A quality system covers the whole product lifecycle: pharmaceutical development, technology transfer, commercial manufacturing, and product discontinuation. Its four ICH Q10 elements are process performance and product quality monitoring, CAPA, change management, and management review. The quality system is not itself an enforceable rule. Inspectors cite the underlying part, 21 CFR Part 211 for finished drugs or 21 CFR Part 820 for devices.

A quality system is applied through the unit that holds release authority and the written procedures binding it. 21 CFR 211.22 requires a quality control unit with authority to approve or reject components, in-process materials, packaging, labeling, and drug products, plus authority to review production records, and requires those responsibilities and procedures to be written and followed.

Not to be confused with

GMP
GMP is the enforceable minimum for how product is made, controlled, and released. A quality system is the management layer above it, which is why a site can pass a GMP inspection and still have no functioning management review.
ICH Q10
Q10 is one guidance model of a pharmaceutical quality system, not the system itself and not law. Q10 explicitly does not create expectations beyond current regulatory requirements; you operate the quality system, Q10 describes what a good one looks like.
21 CFR Part 820 / QMSR
the device-side quality system requirement, which since 2 February 2026 incorporates ISO 13485:2016 by reference. Finished drugs remain under 21 CFR Part 211, which that rule did not touch.
Quality control unit
the QCU is one organisational component inside a quality system, defined by its release authority under 21 CFR 211.22. The quality system is the whole framework; the QCU is the part with the authority to say no.

There is no single quality system regulation. The obligations come from the applicable GMP part plus the Q10 model, and these are the anchors.

What you must do

  1. 1Establish, implement, and maintain a system that delivers products with quality attributes meeting the needs of patients, health care professionals, and regulatory authorities, including compliance with approved regulatory filingsICH Q10 §1.5
  2. 2Operate the four quality system elements: process performance and product quality monitoring, CAPA, change management, and management review of process performance and product qualityICH Q10 §3.2
  3. 3Establish a quality control unit with authority to approve or reject all components, containers, closures, in-process materials, packaging material, labeling, and drug products, and to review production records21 CFR 211.22(a)
  4. 4Put the quality control unit's responsibilities and procedures in writing, and follow those written procedures21 CFR 211.22(d)
  5. 5For finished medical devices, operate a quality management system meeting the QMSR, which incorporates ISO 13485:2016 by reference21 CFR Part 820

Common mistakes

  • Building the quality system as documentation instead of management

    A quality manual and a shelf of SOPs satisfy no inspector on their own. ICH Q10 makes management review one of four elements, so a system with no record of senior management acting on process performance data is a system in name only.

  • Scoping the quality system to commercial manufacturing

    ICH Q10 runs from pharmaceutical development through technology transfer, commercial manufacturing, and discontinuation. Teams that start the quality system at launch carry undocumented development decisions into the filing and cannot reconstruct the rationale when a reviewer asks two years later.

  • Assuming one framework covers both drugs and devices

    The two diverged further on 2 February 2026, when the QMSR amended 21 CFR Part 820 to incorporate ISO 13485:2016 while 21 CFR Part 211 was left unchanged. A device-derived procedure set does not discharge Part 211's quality control unit obligations.

When This Matters

  • The auditor asked to see how our quality system feeds deviation trends into management review.
  • That site has a quality system on paper and no evidence anyone acts on it.
  • Our quality system has to cover development, not just commercial manufacturing.

Frequently Asked Questions

No. GMP sets the minimum production and control requirements you are inspected against; a quality system is the management framework above them, adding quality policy, management review, and continual improvement. ICH Q10 states its content beyond current regional GMP requirements is optional, so the two are not interchangeable obligations.

Related Use Cases

Related Regulatory Intelligence

Related Actions

Sources & References

Share this page
Agent CTA Background

Simplify QS compliance